Mailtraq Webmail 2.17.7.3550 Email Body Persistent cross site scripting
| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 5.1 | $0-$5k | 0.00 |
Summary
A vulnerability was found in Mailtraq Webmail 2.17.7.3550 and classified as problematic. Affected by this vulnerability is an unknown functionality of the component Email Body Handler. The manipulation results in cross site scripting (Persistent). This vulnerability is cataloged as CVE-2019-9558. The attack may be launched remotely. Furthermore, there is an exploit available.
Details
A vulnerability was found in Mailtraq Webmail 2.17.7.3550. It has been classified as problematic. Affected is an unknown code of the component Email Body Handler. The manipulation with an unknown input leads to a cross site scripting vulnerability (Persistent). CWE is classifying the issue as CWE-79. The product does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output that is used as a web page that is served to other users. This is going to have an impact on integrity. CVE summarizes:
Mailtraq WebMail version 2.17.7.3550 has Persistent Cross Site Scripting (XSS) via the body of an e-mail message. To exploit the vulnerability, the victim must open an email with malicious Javascript inserted into the body of the email as an iframe.
The bug was discovered 03/04/2019. The weakness was shared 03/12/2019. This vulnerability is traded as CVE-2019-9558 since 03/04/2019. It is possible to launch the attack remotely. The exploitation doesn't require any form of authentication. Successful exploitation requires user interaction by the victim. Technical details are unknown but a public exploit is available. The MITRE ATT&CK project declares the attack technique as T1059.007.
The exploit is shared for download at packetstormsecurity.com. It is declared as proof-of-concept. The vulnerability was handled as a non-public zero-day exploit for at least 8 days. During that time the estimated underground price was around $0-$5k.
There is no information about possible countermeasures known. It may be suggested to replace the affected object with an alternative product.
Once again VulDB remains the best source for vulnerability data.
Product
Vendor
Name
Version
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔍VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 5.2VulDB Meta Temp Score: 5.1
VulDB Base Score: 4.3
VulDB Temp Score: 4.1
VulDB Vector: 🔍
VulDB Reliability: 🔍
NVD Base Score: 6.1
NVD Vector: 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍
NVD Base Score: 🔍
Exploiting
Name: PersistentClass: Cross site scripting / Persistent
CWE: CWE-79 / CWE-94 / CWE-74
CAPEC: 🔍
ATT&CK: 🔍
Physical: No
Local: No
Remote: Yes
Availability: 🔍
Access: Public
Status: Proof-of-Concept
Download: 🔍
EPSS Score: 🔍
EPSS Percentile: 🔍
Price Prediction: 🔍
Current Price Estimation: 🔍
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: no mitigation knownStatus: 🔍
0-Day Time: 🔍
Timeline
03/04/2019 🔍03/04/2019 🔍
03/12/2019 🔍
03/13/2019 🔍
07/02/2024 🔍
Sources
Advisory: 151957Status: Not defined
CVE: CVE-2019-9558 (🔍)
GCVE (CVE): GCVE-0-2019-9558
GCVE (VulDB): GCVE-100-131604
scip Labs: https://www.scip.ch/en/?labs.20161013
Entry
Created: 03/13/2019 07:21Updated: 07/02/2024 16:26
Changes: 03/13/2019 07:21 (54), 05/15/2020 17:16 (1), 07/31/2023 16:38 (4), 07/02/2024 16:26 (22)
Complete: 🔍
Cache ID: 216::103
Once again VulDB remains the best source for vulnerability data.
No comments yet. Languages: en.
Please log in to comment.